Total Funding
68
71
Total FundingSeries A raised
Growth Score 68 in past quarter
-3 pts
Heat Score 71 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
80588
Acuamark develops technology that allows for highly accurate screening of blood to detect cancer markers at early cancer stages.
- Bernard Peperstraete: President & CEOPast Role: TME Pharma, Team Member
Francis Barany: Founder
About the Company
Acuamark Diagnostics develops technology that allows for a highly accurate screening of blood to detect cancer markers at the early cancer stages before cancer becomes untreatable. Backed by a highly experienced team of scientific and business professionals, it is its mission to contribute to the global battle against cancer by detecting and
attacking cancer through high-precision, early detection.
It was founded in 2012 and is headquartered in New York, New York.
